<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-cancers-12-00713">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bermejo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>López-Huertas</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>García-Pérez</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Climent</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Descours</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ambrosioni</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mateos</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Rodríguez-Mora</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rus-Bercial</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Benkirane</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells</article-title>
  <source>Biochem. Pharmacol.</source>
  <year>2016</year>
  <volume>106</volume>
  <fpage>30</fpage>
  <lpage>45</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bcp.2016.02.002</pub-id>
  <pub-id pub-id-type="pmid">26851491</pub-id>
 </element-citation>
</ref>
